This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Endocrine Surgery  • Surgical Oncology  • Liver/ Biliary Tract/ Pancreatic Diseases  • Alert me on articles by topic

Sharon Weber, MD

Arch Surg. 2006;141:56.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In recent years, there have been an increasing number of studies evaluating outcome in patients with IPMN. As noted by the authors, some of these studies have suggested an increased risk of extrapancreatic neoplasms in patients with IPMN. The potential bias in reporting these findings, however, is that patients previously diagnosed with other malignancies are subject to closer surveillance, including a higher number of physician visits and imaging tests, which may increase the likelihood that they are subsequently diagnosed as having IPMN. In addition, because we now understand the significant chance for recurrence of IPMN in the pancreas (up to 23% at 32 months’ median follow-up in a recent series by D’Angelica et al¹ at Memorial Sloan-Kettering), postoperative patients with a new diagnosis of IPMN are closely followed up postoperatively with imaging tests, which may increase the likelihood of discovering other extrapancreatic malignancies. Because of this, it . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED ARTICLE

High Incidence of Extrapancreatic Neoplasms in Patients With Intraductal Papillary Mucinous Neoplasms
Min-Gew Choi, Sun-Whe Kim, Sung-Sik Han, Jin-Young Jang, and Yong-Hyun Park
Arch Surg. 2006;141(1):51-56.
ABSTRACT | FULL TEXT